Short answer
Varex Imaging Corp (VREX) filed its Q2 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Apr 3, 2026. Quarterly revenue was $216M (up 1.5% year over year) with net income of −$8M.
Q2 2026 key financials · XBRL
- Revenue
- $216M
- +1.5% YoY · +3.1% QoQ
- Net income
- −$8M
- −217.4% YoY · −452.2% QoQ
- Operating margin
- 6.7%
- Gross margin
- 33.6%
- EPS (diluted)
- −$0.19
- −211.8% YoY · −480.0% QoQ
Source: XBRL data from the Varex Imaging Corp (VREX) Q2 2026 10-Q on SEC EDGAR. USD.
Varex Imaging Corp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $216.0M, up 1.5% YoY from $212.9M
- Total gross margin 33.6% vs 36.0% YoY
- Industrial strongest segment, revenue $59.8M, up 1.2%; gross margin 36.8% vs 35.2%
- Medical weakest margin, 32.4% vs 36.3%, despite revenue growth of 1.6%
- $490M refinancing, $368M notes redeemed; annual interest expense expected to decline more than $7M
- Tariffs, trade restrictions, supply-chain disruption, and customer purchasing delays remain near-term headwinds
Risk Factors
- Newly emphasized tariff risk: 2025 U.S.-China policy changes affected profitability through first-half fiscal 2026
- Regulatory risk: MOFCOM investigations could impose tariffs on U.S.-origin CT Tubes and Inserts
- China concentration: Medical X-ray tube imports represented 11% of first-half fiscal 2026 revenue
- Customer concentration: One customer represented 19% of quarterly revenue and 13% of accounts receivable
- International exposure: Customers outside the United States generated 68% of first-half fiscal 2026 revenue
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Varex Imaging Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.